• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-1(IL-1)诱导的TAK1依赖性与MEKK3依赖性核因子κB激活途径在IL-1受体相关激酶修饰处发生分支。

Interleukin-1 (IL-1)-induced TAK1-dependent Versus MEKK3-dependent NFkappaB activation pathways bifurcate at IL-1 receptor-associated kinase modification.

作者信息

Yao Jianhong, Kim Tae Whan, Qin Jinzhong, Jiang Zhengfan, Qian Youcun, Xiao Hui, Lu Yi, Qian Wen, Gulen Muhammet Fatih, Sizemore Nywana, DiDonato Joseph, Sato Shintaro, Akira Shizuo, Su Bing, Li Xiaoxia

机构信息

Department of Immunology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

出版信息

J Biol Chem. 2007 Mar 2;282(9):6075-89. doi: 10.1074/jbc.M609039200. Epub 2006 Dec 29.

DOI:10.1074/jbc.M609039200
PMID:17197697
Abstract

Interleukin-1 (IL-1) receptor-associated kinase (IRAK) is phosphorylated after it is recruited to the receptor, subsequently ubiquitinated, and eventually degraded upon IL-1 stimulation. Although a point mutation changing lysine 134 to arginine (K134R) in IRAK abolished IL-1-induced IRAK ubiquitination and degradation, mutations of serines and threonines adjacent to lysine 134 to alanines ((S/T)A (131-144)) reduced IL-1-induced IRAK phosphorylation and abolished IRAK ubiquitination. Through the study of these IRAK modification mutants, we uncovered two parallel IL-1-mediated signaling pathways for NFkappaB activation, TAK1-dependent and MEKK3-dependent, respectively. These two pathways bifurcate at the level of IRAK modification. The TAK1-dependent pathway leads to IKKalpha/beta phosphorylation and IKKbeta activation, resulting in classical NFkappaB activation through IkappaBalpha phosphorylation and degradation. The TAK1-independent MEKK3-dependent pathway involves IKKgamma phosphorylation and IKKalpha activation, resulting in NFkappaB activation through IkappaBalpha phosphorylation and subsequent dissociation from NFkappaB but without IkappaBalpha degradation. These results provide significant insight to our further understanding of NFkappaB activation pathways.

摘要

白细胞介素-1(IL-1)受体相关激酶(IRAK)在被招募到受体后发生磷酸化,随后被泛素化,并最终在IL-1刺激下被降解。尽管IRAK中赖氨酸134突变为精氨酸(K134R)的点突变消除了IL-1诱导的IRAK泛素化和降解,但赖氨酸134附近的丝氨酸和苏氨酸突变为丙氨酸((S/T)A (131 - 144))会降低IL-1诱导的IRAK磷酸化并消除IRAK泛素化。通过对这些IRAK修饰突变体的研究,我们发现了两条平行的IL-1介导的NFκB激活信号通路,分别是TAK1依赖性和MEKK3依赖性的。这两条通路在IRAK修饰水平上分支。TAK1依赖性通路导致IKKα/β磷酸化和IKKβ激活,通过IκBα磷酸化和降解导致经典的NFκB激活。TAK1非依赖性的MEKK3依赖性通路涉及IKKγ磷酸化和IKKα激活,通过IκBα磷酸化以及随后与NFκB解离但不伴有IκBα降解导致NFκB激活。这些结果为我们进一步理解NFκB激活通路提供了重要的见解。

相似文献

1
Interleukin-1 (IL-1)-induced TAK1-dependent Versus MEKK3-dependent NFkappaB activation pathways bifurcate at IL-1 receptor-associated kinase modification.白细胞介素-1(IL-1)诱导的TAK1依赖性与MEKK3依赖性核因子κB激活途径在IL-1受体相关激酶修饰处发生分支。
J Biol Chem. 2007 Mar 2;282(9):6075-89. doi: 10.1074/jbc.M609039200. Epub 2006 Dec 29.
2
The kinase activity of IL-1 receptor-associated kinase 4 is required for interleukin-1 receptor/toll-like receptor-induced TAK1-dependent NFkappaB activation.白细胞介素-1受体相关激酶4的激酶活性是白细胞介素-1受体/ Toll样受体诱导的TAK1依赖性核因子κB激活所必需的。
J Biol Chem. 2008 Nov 14;283(46):31697-705. doi: 10.1074/jbc.M804779200. Epub 2008 Sep 15.
3
TLR8-mediated NF-kappaB and JNK activation are TAK1-independent and MEKK3-dependent.Toll样受体8(TLR8)介导的核因子κB(NF-κB)和应激活化蛋白激酶(JNK)激活不依赖转化生长因子β激活激酶1(TAK1),而依赖丝裂原活化蛋白激酶激酶3(MEKK3)。
J Biol Chem. 2006 Jul 28;281(30):21013-21021. doi: 10.1074/jbc.M512908200. Epub 2006 May 31.
4
Pellino 3b negatively regulates interleukin-1-induced TAK1-dependent NF kappaB activation.佩利诺3b负向调节白细胞介素-1诱导的TAK1依赖性核因子κB激活。
J Biol Chem. 2008 May 23;283(21):14654-64. doi: 10.1074/jbc.M706931200. Epub 2008 Mar 7.
5
IRAK and TAK1 are required for IL-18-mediated signaling.白细胞介素-18介导的信号传导需要白细胞介素-1受体相关激酶(IRAK)和转化生长因子β激活激酶1(TAK1)。
Eur J Immunol. 2001 Dec;31(12):3747-54. doi: 10.1002/1521-4141(200112)31:12<3747::aid-immu3747>3.0.co;2-e.
6
Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol.白细胞介素-1(IL-1)受体相关激酶依赖性IL-1诱导的信号复合物在质膜处使TAK1和TAB2磷酸化,并在细胞质中激活TAK1。
Mol Cell Biol. 2002 Oct;22(20):7158-67. doi: 10.1128/MCB.22.20.7158-7167.2002.
7
IRAK-M mediates Toll-like receptor/IL-1R-induced NFκB activation and cytokine production.IRAK-M 介导 Toll 样受体/IL-1R 诱导的 NFκB 激活和细胞因子产生。
EMBO J. 2013 Feb 20;32(4):583-96. doi: 10.1038/emboj.2013.2. Epub 2013 Feb 1.
8
Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR .聚肌胞苷酸(Poly(I-C))诱导的Toll样受体3(TLR3)介导的核因子κB(NFκB)和丝裂原活化蛋白激酶(MAP激酶)激活是通过一条不依赖白介素-1受体相关激酶(IRAK)的途径,该途径利用信号转导成分TLR3-肿瘤坏死因子受体相关因子6(TRAF6)-转化生长因子β激活激酶1(TAK1)-TAK1结合蛋白2(TAB2)-蛋白激酶R(PKR)。
J Biol Chem. 2003 May 9;278(19):16713-9. doi: 10.1074/jbc.M300562200. Epub 2003 Feb 27.
9
IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-associated kinase phosphorylation and IL-1 responsiveness.白介素-1受体相关激酶磷酸化及白介素-1反应性中,IRAK4激酶活性具有冗余性。
J Biol Chem. 2004 Jun 18;279(25):26748-53. doi: 10.1074/jbc.M400785200. Epub 2004 Apr 14.
10
TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation.TAK1以受体相互作用蛋白(RIP)依赖的方式被招募至肿瘤坏死因子-α(TNF-α)受体1复合物,并与MEKK3协同作用导致NF-κB激活。
J Biol Chem. 2005 Dec 30;280(52):43056-63. doi: 10.1074/jbc.M507807200. Epub 2005 Oct 31.

引用本文的文献

1
Double trouble: cytosolic and nuclear IKKα in cancer.双重麻烦:癌症中的胞质和核内IKKα
Open Biol. 2025 Aug;15(8):240375. doi: 10.1098/rsob.240375. Epub 2025 Aug 6.
2
Sodium Danshensu Inhibits Macrophage Inflammation in Atherosclerosis via the miR-200a-3p/MEKK3/NF-κB Signaling Pathway.丹参素通过miR-200a-3p/MEKK3/NF-κB信号通路抑制动脉粥样硬化中的巨噬细胞炎症
Mol Neurobiol. 2025 May;62(5):5432-5441. doi: 10.1007/s12035-024-04626-2. Epub 2024 Nov 15.
3
DBP Exposure Affects Oocyte Fertilization Via Extracellular Vesicles-Derived miR-116-5p in Ovarian Granulosa Cells Through Downregulating FOXO3a Expression.
舒张压暴露通过下调卵巢颗粒细胞中FOXO3a的表达,经由细胞外囊泡衍生的miR-116-5p影响卵母细胞受精。
Reprod Sci. 2024 Dec;31(12):3858-3869. doi: 10.1007/s43032-024-01559-y. Epub 2024 Jun 10.
4
Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation.通过抑制 MAP3K3 依赖性保护来克服 BRAF 和 CDK4/6 抑制剂耐药性,从而防止 YAP 溶酶体降解。
Exp Mol Med. 2024 Apr;56(4):987-1000. doi: 10.1038/s12276-024-01210-5. Epub 2024 Apr 16.
5
Mycotoxins Zearalenone and Deoxynivalenol Reduce Hepatocyte Innate Immune Response after the Infection by Inhibiting the TLR2/NFκB Signaling Pathway.真菌毒素玉米赤霉烯酮和脱氧雪腐镰刀菌烯醇通过抑制 TLR2/NFκB 信号通路降低乙型肝炎病毒感染后肝细胞固有免疫应答。
Int J Mol Sci. 2023 Jun 2;24(11):9664. doi: 10.3390/ijms24119664.
6
Mutations in the Vicinity of the IRAK3 Guanylate Cyclase Center Impact Its Subcellular Localization and Ability to Modulate Inflammatory Signaling in Immortalized Cell Lines.IRAK3 鸟苷酸环化酶中心附近的突变影响其亚细胞定位和调节永生化细胞系炎症信号的能力。
Int J Mol Sci. 2023 May 10;24(10):8572. doi: 10.3390/ijms24108572.
7
Bone Morphogenetic Proteins Shape T Cells.骨形态发生蛋白塑造T细胞。
Front Immunol. 2022 Mar 28;13:865546. doi: 10.3389/fimmu.2022.865546. eCollection 2022.
8
Acetic acid triggers cytochrome c release in yeast heterologously expressing human Bax.乙酸可触发异源表达人Bax的酵母细胞中细胞色素c的释放。
Apoptosis. 2022 Jun;27(5-6):368-381. doi: 10.1007/s10495-022-01717-0. Epub 2022 Apr 1.
9
Involvement of Interleukin-1 Receptor-Associated Kinase 4 and Interferon Regulatory Factor 5 in the Immunopathogenesis of SARS-CoV-2 Infection: Implications for the Treatment of COVID-19.白细胞介素-1受体相关激酶4和干扰素调节因子5在SARS-CoV-2感染免疫发病机制中的作用:对COVID-19治疗的启示
Front Immunol. 2021 Apr 7;12:638446. doi: 10.3389/fimmu.2021.638446. eCollection 2021.
10
Bone Morphogenic Protein Signaling and Melanoma.骨形态发生蛋白信号与黑色素瘤。
Curr Treat Options Oncol. 2021 Apr 17;22(6):48. doi: 10.1007/s11864-021-00849-w.